High doses of intravenous immunoglobulin (IVIG) in conjunction with an anticoagulant were associated with resolved vaccine-induced immune thrombotic thrombocytopenia (VITT) in three patients, according to a report yesterday in the New England Journal of Medicine.
VITT occurs when antibodies attack protein factor 4 (PF4), leading to blood clumping and clots.
The Florida Department of Health (Florida Health) this week announced that a second local dengue case has been reported from Miami-Dade County, and last week it confirmed another local dengue case in Monroe County, raising the total in the county, which includes the Florida Keys, to 56.
Individualized prescribing feedback and education in a telemedicine practice significantly decreased antibiotic prescribing rates for upper respiratory infection (URI) and bronchitis compared with education alone, US researchers reported yesterday in the Journal of General Internal Medicine.
Tests in the Democratic Republic of Congo (DRC) have confirmed five more Ebola cases in the Equateur province outbreak, lifting the total to 84, the World Health Organization (WHO) African regional office said on Twitter today.
Also, three more people died from their infections, raising the fatality count to 36.
COVID-19 genetic material—not necessarily live virus—was found on surfaces in a 1-meter (3.3-foot) diameter circle where asymptomatic patients who had passed coronavirus triage had eye exams, according to a small study published yesterday in JAMA Ophthalmology.
Officials reported five more illnesses and three more deaths in a new Ebola outbreak in the Democratic Republic of the Congo (DRC), according to figures reported today by the country's multisectoral Ebola response committee (CMRE).
The new developments raise the outbreak total to 17 cases, 14 of them confirmed and 3 listed as probable. The new deaths raise the fatality count to 11.
A study today in Morbidity and Mortality Weekly Report (MMWR) details the first evidence of locally acquired dengue infections on Guam in more than 75 years.
Forge Therapeutics announced today that it will partner with Hoffman-La Roche to develop and commercialize a novel antibiotic for treating serious lung infections caused by antibiotic-resistant gram-negative bacteria.
The antibiotic, developed by Forge through its Fg-LpxC LUNG program, targets and inhibits LpxC, a zinc metalloenzyme found in gram-negative bacteria, using a proprietary chemistry platform.
Vaccine effectiveness was 80.2% in the first 11 months and 73.3% in the first 17 months.
Florida Health officials confirmed a case of locally acquired dengue in the Florida Keys, according to the Associated Press (AP), and said the patient is doing well. The Keys saw outbreaks of the mosquito-borne disease in 2009 and 2010.